NCT05220228View on ClinicalTrials.gov

Prucalopride and Cognition in Recovered Depression

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 4, 2022

Primary Completion Date

November 13, 2023

Study Completion Date

November 13, 2023

Conditions
Depression in Remission
Interventions
DRUG

Prucalopride

1mg prucalopride x 2d, 2mg prucalopride x 5-8d

DRUG

Placebo

Lactose / sucrose placebo

Trial Locations (1)

Unknown

Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford

All Listed Sponsors
lead

University of Oxford

OTHER

NCT05220228 - Prucalopride and Cognition in Recovered Depression | Biotech Hunter | Biotech Hunter